PodcastIntel
Sign in Get Started Free
Dr. Alex Tatem
Dr. Alex Tatem

Retatrutide Dosing Explained (Doctor Breaks Down the Data)

Jun 2, 2026 · 0:18:27
Listen to Episode
✨ AI Summary
  • Retatrutide shows significant weight loss in Phase 3 trials.
  • It's a triple-agonist drug outperforming some GLP-1s.
  • Dr. Tatem breaks down the TRIUMPH-1 data and dosing.

More from Dr. Alex Tatem

Dr. Alex Tatem
How a Drug-Addicted Surgeon Built Modern Surgery
Oct 12, 2026 · 0:27:43
Dr. Alex Tatem
3 TRT Clinic Mistakes Every Man Should Know
Oct 9, 2026 · 0:02:30
Dr. Alex Tatem
Is Modafinil the Real-Life Limitless Drug?
Oct 7, 2026 · 0:02:11
Dr. Alex Tatem
Why Bodybuilders Are Using IGF-1 LR3
Oct 5, 2026 · 0:29:52
View all episodes →

Get AI Summaries for Every New Episode

Subscribe to Dr. Alex Tatem and get AI summaries, guest tracking, and email digests delivered automatically.

Sign Up Free →